Axsome Therapeutics, Inc.

AXSM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents — — —
Accounts Receivable — — —
Inventory — — —
Total Current Assets $35.3M $38.0M $49.0M
Property, Plant & Equipment $68.1K $100.7K $16.7K
Goodwill — — —
Intangible Assets (Excl. Goodwill) — — —
Total Assets $35.6M $38.2M $49.1M
Liabilities
Accounts Payable $3.4M $4.1M $1.9M
Total Current Liabilities $12.2M $7.2M $2.6M
Long-Term Debt $6.7M $9.5M —
Total Liabilities $18.8M $16.6M $2.6M
Stockholders' Equity
Retained Earnings $-76.6M $-47.6M $-20.4M
Total Stockholders' Equity $16.7M $21.6M $46.4M
← Newer Page 2 of 2 Older →